Top 50 Medical Startup Investors in Oceania in September 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Oceania. We rank investors based on the number of investments they made in Medical companies from Oceania. We update this investor list every month.Top 50 Medical Startup Investors in Oceania in September 2025
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Pre-Seed, Series A
- Australia, United States, Hong Kong
Portfolio highlights
- Voltavate — Voltavate is dedicated to driving innovation in battery technology to support the global transition towards sustainable energy solutions.
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
- SAMA Fertility — SAMA Fertility is a virtual fertility clinic that offers fertility care and treatments, including preservation and evaluation services.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Diraq — Diraq aims to redefine scalable quantum computing and bring practical commercial applications to the world.
- Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Funding Round, Series A
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Series B
- Australia, United States, Philippines
Portfolio highlights
- Diraq — Diraq aims to redefine scalable quantum computing and bring practical commercial applications to the world.
- Levur — Levur produces oils inspired by nature, without the environmental impact. Our vision is a future where reliance on unsustainable plant and animal oils like Palm Oil is drastically reduced, mitigating environmental impacts. We are collaborating with large consumer goods manufacturers to make this a
- QuintessenceLabs — Quantum cyberattacks can break current encryption in minutes! Get protected with QuintessenceLabs quantum key distribution, generation, and management.
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
- SaaS, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- Australia, United States
Portfolio highlights
- Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
- FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
- Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
- Health Care, Information Technology, Software
- Seed, Series A, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
- Great Wrap — The only Australian made and owned compostable cling wrap
- Conserving Beauty — Acne Care Reimagined. Skincare formulated for for acne-prone and sensitive skin. Clinically tested and shown to cause no dermal irritation or sensitization. Australian and STEM Female Founded.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- New Zealand, United States, United Kingdom
Portfolio highlights
- Halter — Halter creates GPS enabled, solar powered collars for cows. The collar hardware allows farmers to use simple tablet app software to remotely set geographic boundaries for cattle, virtual fences. Farmers use Halter's system to avoid physically herding cows, maximizing farmer time and productivity.
- Factor — Plug and play forecasting and pricing tools for modern energy utilities.
- Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Right Click Capital - Australian Venture Capital Firm
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Funding Round
- Australia, Singapore, United States
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
- Health Care, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- United Kingdom, United States, Australia
Portfolio highlights
- Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Seed, Series A
- Australia
Portfolio highlights
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- VitalTrace — VitalTrace develops advanced biosensor technology to support safer childbirth. Our real-time fetal monitoring system helps detect distress during labour, empowering clinicians with data-driven decisions for better outcomes.
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more
Investment focus
- Software, SaaS, Information Technology
- Series A, Seed, Funding Round
- Australia, New Zealand, United States
Portfolio highlights
- Modii — Modii is a leading provider of smart parking solutions, dedicated to transforming the way parking and mobility are managed and experienced through a unified platform of digital infrastructure, data integration, and parking intelligence. By integrating cutting-edge technology with user-friendly platforms, Modii helps institutions, organizations, andurban areas optimize their parking operations, improve efficiency, and enhance user satisfaction by enabling thoughtful parking planning through data-driven insights. For more information about Modii visit modii.co.
- splose — splose isn’t just practice management software. It's your ally in handling the ins-and-outs of running a practice and a savvy tool for growth. At splose, we are dedicated to continuously improving and embracing the power of AI and automation to give healthcare professionals like you more time to focus on what matters most.
- Termina — Termina operates as an energy tech startup.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
- Software, Enterprise Software, Information Technology
- Series A, Series B, Funding Round
- United States, Australia, Philippines
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,303,636 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more
Investment focus
- EdTech, Medical, Education
- Seed
- Australia
Portfolio highlights
- PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
- My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more
Investment focus
- Construction, Software, SaaS
- Funding Round, Seed, Convertible Note
- Australia, United States
Portfolio highlights
- SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
- APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Series A, Pre-Seed
- Australia, United States, New Zealand
Portfolio highlights
- Marloo — Marloo is an AI-assistant that empowers financial advisers to focus on building client relationships, instead of paperwork.
- Syenta — Syenta is transforming the electronics manufacturing sector. Our patented fabrication method enables the 3D printing of multi-material electronics with fewer steps and less waste.
- PsiQuantum — PsiQuantum is building the world's first useful quantum computer.
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
- Software, Information Technology, Apps
- Seed, Series A, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
- Forever Network — Forever Network is a social-first sports media company. Our keystone brand, Basketball Forever, is the worlds largest independent sports media channel.
- Visionary Machines — Superior perception for next-generation autonomy
Kurt Alexander
Show more
Investment focus
- Mining, Retail, Medical
- Seed, Funding Round
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence
We like metrics, traction & perseverance
We invest in people
1/3 of our focus is on Health and Education;
We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research,
chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction
Founders with Insight
Founders with Perseverance and Courage
Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey
Accelerate your business with our portfolios' intellectual capital
Show more
Investment focus
- Software, Education, SaaS
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Go1 — Go1 offers training content from 250+ industry-leading providers, delivered seamlessly through any HR tech stack.
- OneMRI — OneMRI is a provider of comprehensive whole-body MRI scans that are radiation-free, clinically reviewed by radiologists, and explained by doctors.
- Vitruvian Form — Vitruvian manufactures a connected fitness hardware, develops software and fitness class content.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more
Investment focus
- Events, Sports, Cycling
- Pre-Seed
- Hong Kong
Portfolio highlights
- Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
- VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
- Software, Financial Services, FinTech
- Funding Round, Series B, Convertible Note
- Australia, United States, United Kingdom
Portfolio highlights
- Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Investing in great people solving hard problems to create a better future.
Show more
Investment focus
- Medical Device, Medical, Information Technology
- Seed, Series A
- New Zealand, Australia
Portfolio highlights
- PHNXX — PHNXX provides containerised clean and reliable energy solutions for business operations.
- Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
- Green Gravity — Green Gravity is an electric power generation company that enables renewable energy transition using energy storage technology.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more
Investment focus
- Biotechnology, Robotics, Nanotechnology
- Seed
- New Zealand, United States
Portfolio highlights
- Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- PowerON — Dielectric Elastomers for Soft Robotics
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
- Software, Biotechnology, Renewable Energy
- Series A, Series B, Series C
- Australia, United Kingdom, United States
Portfolio highlights
- Airwallex — Grow your business faster with Airwallex - global business accounts, high speed transfers, multi-currency cards, online payments, embedded finance, and more.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Privately Held Companies
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Series C
- United States, Canada, Australia
Portfolio highlights
- Ten Bay Bio — Ten Bay Bio is a biotechnology company that offers biological therapies for treatment of complex diseases in immunology.
- Apreo Health — Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
- Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more
Investment focus
- Medical, Facial Recognition, Artificial Intelligence
- Seed, Funding Round
- Australia
Portfolio highlights
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Qlarifi — Consumer lending decisions transformed with real time, comprehensive data.
- Safewill — Safewill is Australia's leading online Will writing platform. With thousands of users, Safewill makes it easy and affordable to write your own legally binding will
- Ajust — Ajust makes it easy to resolve customer complaints with banks, telcos and energy companies. It's fast, fair and free for consumers.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
- Harrison.ai — And a thirst for knowledge meets a passion for a better world.A world where people are cared for by people, medical data analysis is done at scale,
- Owlstone Medical — Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs.The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novelnon-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease.The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved.Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
- Software, Health Care, SaaS
- Seed, Angel, Series A
- Australia, United States
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Seed, Series A, Funding Round
- Australia, United States
Portfolio highlights
- OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
- PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
- FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Angel
- New Zealand, United States, United Kingdom
Portfolio highlights
- Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
- Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
About
NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and gro...
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Private Equity, Series A, Post-IPO Equity
- United States, New Zealand, United Kingdom
Portfolio highlights
- Mirna — Mirna is a veterinary diagnostics company that specializes in the development of veterinary disease testing technology.
- Hansa Biopharma — We are dedicated to developing lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.
- Phathom Pharmaceuticals — A late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from GI diseases related to acid.
Auckland University's commercialisation arm
Show more
Investment focus
- Medical Device, SaaS, Audio
- Seed, Pre-Seed
- New Zealand
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
SG Hiscock
Show more
Investment focus
- Software, Legal, Medical
- Series A, Funding Round
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- Immediation — Sophisticated video conferencing for dispute resolution and legal practice. Built by Lawyers, for Lawyers. Start your free 14-day trial today.
- Marketplacer — Marketplacer is a marketplace platform and dropshipping solution that allows enterprise companies to scale and grow in today's evolving e-commerce environment.
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Debt Financing, Funding Round
- Australia, United States, Israel
Portfolio highlights
- Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
- StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
- Employment Hero — Recruitment, HR, Payroll & Benefits in one place - designed for small & medium businesses to be efficient, compliant & cost-Effective. Book a demo today!
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Debt Financing
- United Kingdom, Australia, United States
Portfolio highlights
- nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
- Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
- Lumin Solutions — Making care recording simpler, safer & child-focused for UK youth care providers. MyLifePlan helps you save time, ensure compliance & deliver outstanding care. Discover how!
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Show more
Investment focus
- Sensor, Medical, Wearables
- Funding Round
- Australia
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Series C
- United States, United Kingdom, Canada
Portfolio highlights
- Totus Medicines — Applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.
- SeLux Diagnostics — SeLux Diagnostics is a developer of the Next-Generation Phenotyping (NGP) platform that enables personalized antibiotic therapies for patients. The company was founded in 2014 and is based in Charlestown, MA.
- Elephas — Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Championing the next generation of B2B technology startups.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Pre-Seed, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- 8seats — 8seats offers a secure, effortless messaging app for teams! Boost productivity with real-time chat, team collaboration for businesses of any size. Get started for free!
- Nullify — Nullify performs product security tasks alongside your developers.
- Altai — Altai is a bespoke casting platform which offers unparalleled collaboration between Artists, Agents, Casting Directors and Clients.
Donald Kirk
Show more
Investment focus
- Mining, Retail, Medical
- Seed
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
CVC has seven complementary strategies across private equity, secondaries and credit, through which we invest on behalf of pension funds and other leading institutions
Show more
Investment focus
- Software, Financial Services, Retail
- Private Equity, Post-IPO Equity, Funding Round
- United States, United Kingdom, Indonesia
Portfolio highlights
- Odevo — We are on a mission to become the leading force within property management and residential services through the combined power of people and technology. Join us.
- Hempel — We help you protect your most valuable assets with our high-quality coatings
- DealStack — Dealstack is the operating system for private capital, built for private capital, by private capital professionals.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more
Investment focus
- Manufacturing, Health Care, Software
- Funding Round, Series A, Seed
- Australia, United States, Philippines
Portfolio highlights
- EntroMat — EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders.
- Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
- Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Ip Group Australia build and support outstanding intellectual property-based companies.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Seed, Pre-Seed, Series A
- Australia, New Zealand
Portfolio highlights
- Azaneo — Azaneo develops lightning-fast electric weeding technology. Using only electrons - herbicide free.
- Hysata — Hysata is a developer of hydrogen electrolyzer designed to accelerate the world's shift away from fossil fuels to green hydrogen
- ElectraLith — ElectraLith develops direct lithium extraction and refining technology designed for efficient and sustainable lithium production.
Great tech startup businesses are built by amazing product teams
Show more
Investment focus
- Medical, Health Care, Pharmaceutical
- Seed
- Australia
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- Elita — Store your dog's stem cells with Elita. One-time opportunity to protect their future health and avoid costly surgeries later in life.
Stephen Baxter - Founder @ River City Labs
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Pre-Seed, Angel
- Australia
Portfolio highlights
- Go1 — Go1 offers training content from 250+ industry-leading providers, delivered seamlessly through any HR tech stack.
- Travelshoot — Your holidays are really important to us to create good memories and we are offering Worldwide Photographer Services. Get the best vacation photographer NYC & across the globe. Visit us now!
- Car Next Door — Hire a car, van or ute from our community of local car owners, or rent out your car and make extra money. Peer-to-peer car share in Sydney, Melbourne, Newcastle.
Healthcare Ventures is an investment fund that invests in people and technologies that focuses on the data and technology of healthcare. Healthcare Ventures specializes in the fields of venture capital, private equity, and financial services.
Show more
Investment focus
Portfolio highlights
- Evidentli — Our technology standardises complex healthcare data with over 99% accuracy in days, not months; in weeks, not years.
Andrew R Banks
Show more
Investment focus
- Grocery, Medical, Health Care
- Seed
- Australia
Portfolio highlights
- Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
- Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
Pollenizer is a co-founder of start-up web businesses in Australia. They partner with strong founders and take equity stakes at a concept stage on consumer and SaaS businesses. The skill sets cover technology, marketing and capital raising. They also occasionally make seed investments. Their businesses include;* * ** * * * * * * * * * Their team includes;* Phil Morle, ex-CTO of Kazaa, Omnidrive.* Mick Liubinskas, ex-CMO of Kazaa, Tangler, ZaprThey are also investors and partners with
Show more
Investment focus
- E-Commerce, B2B, Marketplace
- Seed, Angel, Funding Round
- Australia
Portfolio highlights
- LawPath — Create legal documents, manage compliance and connect with lawyers on demand. Less stress, more time and better business. Sign up for free.
- CohortIQ — cohortiQ Home Page
- HiveXchange — Designed and built in Australia for the fresh produce industry. Find opportunities, create private offers, make product requests, get notified of deals in real time. Trade easy.
Investors by industry
Google
Marketplace
Hardware
Energy
Proptech
Health Care
Biotech
Artificial intelligence
Climate
Consumer
Community
Impact
Gaming
FinTech
EdTech
Sustainability
Venture Capital
Big Data
Web3
B2B
Financial Services
Finance
Infrastructure
Education
Photography
Payments
Food and Beverage
Video Games
Organic Food
Retail
Beauty
Publishing
Clean Energy
Real Estate
Manufacturing
Art
Music
Android
Internet
Enterprise Software
eSports
Franchise
Sports
Construction
Digital Media
Email
Medical
Social Network
Wellness
Social Media
Mobile
Legal
Local
Recruiting
Cannabis
Platforms
Fitness
Travel
Mobile Advertising
Biotechnology
Hospitality
Social
Automotive
Crowdfunding
Wine And Spirits
Medical Device
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Canada
South Korea
Ireland
United States
New Zealand
India
Germany
Australia
Armenia
South Africa
Spain
Japan
Africa
Bulgaria
China
Belize
Bahrain
Croatia
Sri Lanka
Singapore
Georgia
Belarus
Hungary
France
Qatar
Asia
Ghana
Ethiopia
Gibraltar
Chile
Indonesia
Egypt
Vietnam
Finland
Costa Rica
Oceania
Greece
Barbados
Belgium
Estonia
LATAM
Bermuda
Czech Republic
Middle East
Europe
Denmark
Saudi Arabia
Algeria
Hong Kong
Ecuador
Brazil
Faroe Islands
Liechtenstein
Liberia
Lebanon
Mauritius
Sierra Leone
El Salvador
Peru
Norway
Uganda
Israel
Venezuela
Malaysia
Mexico
Nicaragua
Sweden
Jersey
Panama
Morocco
Mali
Slovenia
Lithuania
Italy
Poland
Philippines
Uruguay
Kuwait
Malta
Myanmar
Ukraine
Dominican Republic
Azerbaijan
Iceland
Nigeria
Tajikistan
Puerto Rico
Bahamas
Portugal
Namibia
Iraq
United Arab Emirates
Jamaica
Honduras
Tunisia
Isle of Man
Bolivia
Luxembourg
Taiwan
Pakistan
Albania
Tanzania
Turkey
San Marino
Senegal
Grenada
Jordan
Romania
Bangladesh
Argentina
Kazakhstan
Kenya
Cayman Islands
Cambodia
Togo
Uzbekistan
Serbia
Russian Federation
Zambia
Rwanda
Zimbabwe
Thailand
Oman
Latvia
Guatemala
Cyprus
Austria
Switzerland
Cameroon
Colombia
Marshall Islands
Seychelles
Investors in Oceania by industry
Restaurants
Crowdfunding
Retail
Social
Cryptocurrency
Finance
Food and Beverage
Real Estate
Video Games
Medical
Organic Food
Wine And Spirits
Wellness
Medical Device
Non Profit
Email
Enterprise
Internet
Social Media
Social Network
Art
Manufacturing
Music
Digital Media
Android
Mobile
Legal
Construction
Local
Software
Financial Services
eSports
Enterprise Software
Sports
Fitness
Hospitality
Automotive
CleanTech
Travel
Platforms
FinTech
Biotechnology
Cannabis
Consumer
Health Care
Biotech
Energy
EdTech
Climate
Sustainability
Impact
Proptech
Marketplace
SaaS
Community
Hardware
Beauty
B2B
Fashion
Web3
Life Science
Big Data
Blockchain
Publishing
Sporting Goods
Clean Energy
Education
Oil and Gas
Renewable Energy
Social Impact
Infrastructure
Mobile Apps
Photography
Artificial intelligence
Transportation
Venture Capital
Agriculture (agtech)
Facebook
Media (entertainment)
Machine Learning
InsurTech
Recruiting
Gaming
Payments